ACTION ITEMS FOR SIDMA MEMBERS
KEY MARKET TRENDS & POLICY ENABLERS
- Manufacturing Localization Drive: PLI scheme showing measurable results; domestic production of high-end devices (MRI, CT, LINAC) now occurring
- Regulatory Clarity: CDSCO risk classifications removing ambiguity; faster approvals possible with clear pathways
- R&D Funding: RDI Fund ₹1 lakh crore making capital available for commercialization; phased manufacturing programs for component suppliers
- Export Gateways: WHX Dubai (Feb 9-12), MEDICA (Nov 16-19) providing structured export channels to Middle East, Europe, Global South
- Tariff Protection Debates: Ongoing discussions on import duty elevation could significantly impact market dynamics for Indian manufacturers
- Infrastructure: Medical Device Parks (YEIDA by March 2027, others by 2027-28) offering clustered manufacturing with shared testing facilities
- Procurement Autonomy: GFR amendments enabling R&D institutions to procure specialized equipment directly, bypassing GeM – increases equipment demand
IMMEDIATE ACTION TABLE
| Timeframe | Event | Recommended Action |
| Jan 15 | NCSTC 2026 | Participate for export compliance clarity; understand SCOMET classifications |
| Jan 23-26 | Odisha Medical Expo | Explore Tier II city market opportunities |
| Jan 29-31 | Medical Fair India, New Delhi | Premier showcase; secure booth space early |
| Feb 12-14 | ISCR Clinical Research Conference | Network with researchers; understand regulatory trends |
| Feb 16-18 | BioAsia 2026, Hyderabad | Connect with biotech equipment buyers; startup ecosystem |
| Feb 23-25 | AHCI 2026 | Healthcare tourism and hospital infrastructure partnerships |
| Feb 21-23 | Multiple Regional Events | Medicall (Kolkata), HOSPEX (Ahmedabad) – geographic diversification |
| Feb 9-12 | WHX Dubai | Register for India Pavilion (via EEPC/PEPC) for Middle East market access |
| Ongoing | Engagement with EPCMD | Explore export promotion support, buyer-seller meets |